(VIANEWS) – Cameco Corporation (CCJ), United Therapeutics Corporation (UTHR), CubeSmart (CUBE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Cameco Corporation (CCJ)
26.3% sales growth and 4.23% return on equity
Cameco Corporation produces and sells uranium. It operates in two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles or reactor components for CANDU reactors. The company sells its uranium and fuel services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.
Earnings Per Share
As for profitability, Cameco Corporation has a trailing twelve months EPS of $0.43.
PE Ratio
Cameco Corporation has a trailing twelve months price to earnings ratio of 92.98. Meaning, the purchaser of the share is investing $92.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.23%.
Sales Growth
Cameco Corporation’s sales growth for the next quarter is 26.3%.
Previous days news about Cameco Corporation(CCJ)
- According to Zacks on Wednesday, 18 September, "Peers Cameco Corporation (CCJ Quick QuoteCCJ – Free Report) and Uranium Energy Corp. (UEC Quick QuoteUEC – Free Report) declined 7.3% and 23.2%, respectively.", "The company is, however, cheaper than peers Cameco Corporation and Uranium Energy’s price-to-sales ratios of 7.39 and 19.54, respectively."
2. United Therapeutics Corporation (UTHR)
19.5% sales growth and 19.25% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $21.77.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 16.19. Meaning, the purchaser of the share is investing $16.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.25%.
3. CubeSmart (CUBE)
16.6% sales growth and 14.15% return on equity
CubeSmart is a self-administered and self-managed real estate investment trust. The Company's self-storage properties are designed to offer affordable, easily accessible and secure storage space for residential and commercial customers. According to the 2020 Self-Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the United States.
Earnings Per Share
As for profitability, CubeSmart has a trailing twelve months EPS of $1.78.
PE Ratio
CubeSmart has a trailing twelve months price to earnings ratio of 29.94. Meaning, the purchaser of the share is investing $29.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.15%.
Yearly Top and Bottom Value
CubeSmart’s stock is valued at $53.30 at 20:22 EST, below its 52-week high of $53.80 and way above its 52-week low of $33.17.
Volume
Today’s last reported volume for CubeSmart is 1004290 which is 16.16% below its average volume of 1197970.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Oct 1, 2024, the estimated forward annual dividend rate is 2.04 and the estimated forward annual dividend yield is 3.83%.
4. Sprouts Farmers Market (SFM)
9.4% sales growth and 27.7% return on equity
Sprouts Farmers Market, Inc. offers fresh, natural, and organic food products in the United States. The company offers perishable product categories, including fresh produce, meat, seafood, deli, bakery, floral and dairy, and dairy alternatives; and non-perishable product categories, such as grocery, vitamins and supplements, bulk items, frozen foods, beer and wine, and natural health and body care. As of January 2, 2022, it operated 374 stores in 23 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Sprouts Farmers Market has a trailing twelve months EPS of $3.18.
PE Ratio
Sprouts Farmers Market has a trailing twelve months price to earnings ratio of 31.97. Meaning, the purchaser of the share is investing $31.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.7%.
Volume
Today’s last reported volume for Sprouts Farmers Market is 332704 which is 76.06% below its average volume of 1390220.
Previous days news about Sprouts Farmers Market(SFM)
- Sprouts farmers market and tenaris have been highlighted as zacks bull and bear of the day. According to Zacks on Tuesday, 17 September, "Chicago, IL - September 17, 2024 - Zacks Equity Research shares Sprouts Farmers Market (SFM Quick QuoteSFM – Free Report) as the Bull of the Day and Tenaris (TS Quick QuoteTS – Free Report) as the Bear of the Day. "
5. NBT Bancorp (NBTB)
8.6% sales growth and 9.1% return on equity
NBT Bancorp Inc., a financial holding company, provides commercial banking, retail banking, and wealth management services. Its deposit products include demand deposit, savings, negotiable order of withdrawal, money market deposit, and certificate of deposit accounts. The company's loan portfolio comprises commercial and industrial, commercial real estate, agricultural, and commercial construction loans; indirect and direct consumer, home equity, mortgages, business banking loans, and commercial loans; and residential real estate loans. It also provides trust and investment services; financial planning and life insurance services; and retirement plan consulting and recordkeeping services. In addition, the company offers insurance products comprising personal property and casualty, business liability, and commercial insurance, as well as other products and services through 24-hour online, mobile, and telephone channels that enable customers to check balances, make deposits, transfer funds, pay bills, access statements, apply for loans, and access various other products and services. As of December 31, 2020, it had 141 branches and 176 ATMs in New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine. NBT Bancorp Inc. was founded in 1856 and is headquartered in Norwich, New York.
Earnings Per Share
As for profitability, NBT Bancorp has a trailing twelve months EPS of $2.57.
PE Ratio
NBT Bancorp has a trailing twelve months price to earnings ratio of 19.05. Meaning, the purchaser of the share is investing $19.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.1%.
Moving Average
NBT Bancorp’s value is way above its 50-day moving average of $44.15 and way above its 200-day moving average of $38.57.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 8.3% and positive 1.4% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 516.78M for the twelve trailing months.
Yearly Top and Bottom Value
NBT Bancorp’s stock is valued at $48.96 at 20:22 EST, under its 52-week high of $50.84 and way higher than its 52-week low of $30.31.
Previous days news about NBT Bancorp(NBTB)
- According to Zacks on Wednesday, 18 September, "Investors might want to bet on NBT Bancorp (NBTB Quick QuoteNBTB – Free Report) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). "
